[1]Nucleosides,nucleotidesandnucleicacids,2003,vol.22,#5-8,p.583-587
[2]TheJournaloforganicchemistry,2002,vol.67,#22,p.7887-7889
[3]Patent:US2003/225262,2003,A1,.Locationinpatent:Pagecolumn34-35
[1]Patent:US2008/234475,2008,A1,.Locationinpatent:Page/Pagecolumn8
[2]Patent:US2008/234475,2008,A1,.Locationinpatent:Page/Pagecolumn8
[1]Nucleosides,NucleotidesandNucleicAcids,2008,vol.27,#9,p.1024-1033
[1]Nucleosides,NucleotidesandNucleicAcids,2003,vol.22,#5-8,p.1327-1330
[1]Nucleosides,nucleotidesandnucleicacids,2003,vol.22,#5-8,p.583-587
Title: Process research on the preparation of DMT protected 2'-O-methoxyethylguanosine for oligonucleotide synthesis in therapeutic applications.
Journal: Nucleosides, nucleotides & nucleic acids 20080901
Title: Synthesis of 2'-O-methoxyethylguanosine using a novel silicon-based protecting group.
Journal: The Journal of organic chemistry 20021101
Title: McPherson AK, et, al. An Improved Process for the Manufacture of 5′-O-(4,4′-Dimethoxytrityl)-N2-isobutyryl-2′-O-(2-methoxyethyl)guanosine. Org. Process Res. Dev. 2020, 24, 11, 2583-2590.
Title: Saleh AF, et, al. 2'-O-(2-Methoxyethyl) Nucleosides Are Not Phosphorylated or Incorporated Into the Genome of Human Lymphoblastoid TK6 Cells. Toxicol Sci. 2018 May 1;163(1):70-78.